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Abstract: Background The immune checkpoint molecule PD‐L1 represents an important target in onco-
logical immune therapy. The aim of our study was to evaluate PD‐L1 expression and the composition
of the tumor microenvironment (TME) in Kaposi sarcoma. Methods Immunohistochemical stains were
performed for PD‐L1, CD3, CD33, CD68, and CD168 in 24 Kaposi sarcoma samples. In PD‐L1‐positive
cases, the double stains for PD‐L1, CD31, podoplanin, and HHV8 were added. Results PD‐L1 was
observed in 71% of the samples and was predominantly located in the TME. PD‐L1 expression was sig-
nificantly higher in nodular stage than in patch/plaque stage. The TME consisted of CD68+/CD163+
macrophages, CD33+ myloid‐derived suppressor cells and monocytes and CD3+ T‐cells. The TME
showed a peritumoral distribution in nodular stage, in contrast to a diffuse distribution in patch/plaque
stage. In 12 samples (50%), no plasma cells were found. Conclusion In nodular stage of KS, the TME
is pushed back in the periphery of the tumor nodules. The PD‐L1‐positive TME between the tumor
cells might protect them from the immune attack. An anti‐PD‐L1 treatment might be promising in KS
patients.
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